ProMIS Neurosciences Has Selected The Lead Vaccine Candidate, PMN400, Against Multiple Synucleinopathies Including Multiple System Atrophy, Parkinson's Disease And Lewy Body Dementia
ProMis Neurosciences 已选择主要候选疫苗 PMN400,以对抗多种突触核病,包括多系统萎缩、帕金森氏病和路易体痴呆